Ligand Pharmaceuticals (LGND) EPS (Basic) (2010 - 2026)
Ligand Pharmaceuticals' (LGND) quarterly EPS (Basic) came in at -$0.67 in Q1 2026, up 69.68% year-on-year from -$0.39 in Q1 2025, and down 128.76% quarter-over-quarter from $2.33 in Q4 2025.
Ligand Pharmaceuticals (LGND) EPS (Basic) (2010 - 2026) Analysis & Trends
Ligand Pharmaceuticals has disclosed EPS (Basic) across 17 years of filings, most recently posting -$0.67 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.67, up 69.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 (up 209.72% YoY), and the FY2025 annual result was $6.44, up 3027.27% from the prior year.
- EPS (Basic) came in at -$0.67 for Q1 2026 at Ligand Pharmaceuticals, down from $2.33 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $5.99 in Q3 2025 to a low of -$2.88 in Q2 2024.
- The 5-year median for EPS (Basic) is -$0.05 (2022), against an average of $0.4.
- Across the five-year window, EPS (Basic) slumped 3050.0% in 2023 and soared 1635.9% in 2025, its largest moves.
- Ligand Pharmaceuticals' EPS (Basic) stood at -$0.86 in 2022, then jumped by 210.47% to $0.95 in 2023, then slumped by 281.05% to -$1.72 in 2024, then jumped by 235.47% to $2.33 in 2025, then tumbled by 128.76% to -$0.67 in 2026.
- The last three EPS (Basic) figures came in at -$0.67 (Q1 2026), $2.33 (Q4 2025), and $5.99 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Ligand Pharmaceuticals | 5.47 Bn | 4.69 Bn | 48.45 Mn | -0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.67 |
| Dec 31, 2025 | 2.33 |
| Sep 30, 2025 | 5.99 |
| Jun 30, 2025 | 0.25 |
| Mar 31, 2025 | -2.21 |
| Dec 31, 2024 | -1.72 |
| Sep 30, 2024 | -0.39 |
| Jun 30, 2024 | -2.88 |
| Mar 31, 2024 | 4.86 |
| Dec 31, 2023 | 0.95 |
| Sep 30, 2023 | -0.59 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 2.56 |
| Dec 31, 2022 | -0.86 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | -0.05 |
| Mar 31, 2022 | -0.91 |
| Dec 31, 2021 | -0.19 |
| Sep 30, 2021 | 1.22 |
| Jun 30, 2021 | 2.19 |